Cambrex Solutions
-
Complex Synthetic Molecule Development, Manufacturing
11/12/2024
See how our innovative capabilities and advanced technologies can optimize the development and manufacturing of complex synthetics for drug substances, medical devices, and diagnostic agents.
-
Your Molecule. Our Mission.
11/12/2024
Our scientists excel at building connections. Start a conversation today and discover the benefits of partnering with a collaborative CDMO.
-
Nitrosamines Capabilities
8/22/2024
Pinpoint impurities and conduct confirmatory testing under cGMP with the help of an expert team utilizing cutting-edge mass spectrometry technology to boost your drug product development.
-
Lab Equipment & Testing Site Matrix
Our analytical and testing services are offered as both standalone services as well as complementing our expertise in drug substance and drug product development and manufacturing depending on your specific program needs.
-
Cleanroom Capabilities And Expertise
Learn how the right partner can ensure that your facilities maintain cGMP-compliance and help establish the correct testing program and parameters based on your needs.
-
A Comprehensive Method Development Experience
Our combined method development experience ensures that client methods are robust, effective, flexible, innovative and allow true stability indication.
-
Continuous Flow
Our team of experts can assess processes for suitable application of continuous flow culminating in the custom development of processes incorporating proof-of-concept to cGMP manufacturing and commercialization.
-
Peptide Crystallization
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.
-
High Potent APIs
Discover how Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.
-
Controlled Substances
Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.